Our analysis focused on papillary thyroid carcinomas (PTCs) samples with two risk factors: BRAF mutation status (a categorical risk factor) and age of diagnosis (a continuous risk factor). The gene discussed is BRAF; the disease is differentiated thyroid carcinoma.